Custom Manufacturing, Project Outsourcing, your Trusted Partner from China
Pulmonary Hypertension (PH) is a severe and progressive condition, necessitating highly effective and safe treatment options. The development of such crucial medications, like Riociguat, hinges entirely on the quality and purity of their Active Pharmaceutical Ingredient (API) components. NINGBO INNO PHARMCHEM CO.,LTD. specializes in providing the precise API raw materials required for these advanced therapies, ensuring the integrity and efficacy of the final drug product.
One key intermediate in the synthesis of Riociguat is 1-(2-Fluorobenzyl)-1H-Pyrazolo[3,4-b]Pyridine-3-Carbonitrile, identified by CAS 256376-65-5. This compound is not just another chemical; it's a critical building block whose structural accuracy and purity directly impact the success of Riociguat intermediate synthesis. Pharmaceutical companies and researchers developing pulmonary hypertension treatments cannot afford compromises on quality. NINGBO INNO PHARMCHEM CO.,LTD. stands as a reliable supplier, offering this essential compound with guaranteed high purity and comprehensive documentation.
The stringent requirements for drug manufacturing mean that sourcing API components must be approached with utmost diligence. NINGBO INNO PHARMCHEM CO.,LTD. implements rigorous quality assurance protocols, from raw material sourcing to final product delivery. This meticulous attention to detail ensures that our 1-(2-Fluorobenzyl)-1H-Pyrazolo[3,4-b]Pyridine-3-Carbonitrile (CAS 256376-65-5) is consistently of the highest quality, suitable for even the most sensitive pharmaceutical applications. For those looking to buy high purity API raw materials for complex drug formulations, our commitment to excellence provides a distinct advantage.
Furthermore, the logistical challenges of obtaining specialized compounds for Riociguat API development chemicals are often underestimated. NINGBO INNO PHARMCHEM CO.,LTD. streamlines this process, offering efficient supply chains for bulk purchase of 1-(2-Fluorobenzyl)-1H-Pyrazolo[3,4-b]Pyridine-3-Carbonitrile. Our robust distribution network ensures timely delivery, supporting continuous production schedules and accelerating the development of new treatments for pulmonary hypertension. As a dedicated pharmaceutical intermediate manufacturer, we are committed to being a pivotal partner in advancing therapies that improve patients' lives worldwide. Our expertise as an API raw material supplier makes us a trusted choice for your critical needs.
Manufacturing Facilities
Professional Export Experience
to Global Customers
1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;
2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;
3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).
A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.
A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.
A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.
